These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 35476986)

  • 1. PITing it forward: A new link in the journey of uropathogenic E. coli in the urothelium.
    Joshi CS; Cegelski L; Mysorekar IU
    Cell Rep; 2022 Apr; 39(4):110758. PubMed ID: 35476986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Virulence factors of uropathogenic E. coli and their interaction with the host.
    Lüthje P; Brauner A
    Adv Microb Physiol; 2014; 65():337-72. PubMed ID: 25476769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetically diverse uropathogenic
    Sintsova A; Frick-Cheng AE; Smith S; Pirani A; Subashchandrabose S; Snitkin ES; Mobley H
    Elife; 2019 Oct; 8():. PubMed ID: 31633483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A non-canonical autophagy-dependent role of the ATG16L1
    Wang C; Bauckman KA; Ross ASB; Symington JW; Ligon MM; Scholtes G; Kumar A; Chang HW; Twentyman J; Fashemi BE; Xavier RJ; Mysorekar IU
    Autophagy; 2019 Mar; 15(3):527-542. PubMed ID: 30335568
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogenic modulation of uropathogenic Escherichia coli infection pathogenesis in a murine menopause model.
    Wang C; Symington JW; Ma E; Cao B; Mysorekar IU
    Infect Immun; 2013 Mar; 81(3):733-9. PubMed ID: 23264047
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virulence behavior of uropathogenic Escherichia coli strains in the host model Caenorhabditis elegans.
    Schifano E; Marazzato M; Ammendolia MG; Zanni E; Ricci M; Comanducci A; Goldoni P; Conte MP; Uccelletti D; Longhi C
    Microbiologyopen; 2019 Jun; 8(6):e00756. PubMed ID: 30381890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urinary tract infection: Pathogenicity, antibiotic resistance and development of effective vaccines against Uropathogenic Escherichia coli.
    Asadi Karam MR; Habibi M; Bouzari S
    Mol Immunol; 2019 Apr; 108():56-67. PubMed ID: 30784763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ferritinophagy drives uropathogenic Escherichia coli persistence in bladder epithelial cells.
    Bauckman KA; Mysorekar IU
    Autophagy; 2016 May; 12(5):850-63. PubMed ID: 27002654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of D-mannose in urinary tract infections - a narrative review.
    Ala-Jaakkola R; Laitila A; Ouwehand AC; Lehtoranta L
    Nutr J; 2022 Mar; 21(1):18. PubMed ID: 35313893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rapid Growth of Uropathogenic
    Forsyth VS; Armbruster CE; Smith SN; Pirani A; Springman AC; Walters MS; Nielubowicz GR; Himpsl SD; Snitkin ES; Mobley HLT
    mBio; 2018 Mar; 9(2):. PubMed ID: 29511075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developments in Mannose-Based Treatments for Uropathogenic Escherichia coli-Induced Urinary Tract Infections.
    Hatton NE; Baumann CG; Fascione MA
    Chembiochem; 2021 Feb; 22(4):613-629. PubMed ID: 32876368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phylogenetic Group B2 Expressed Significant Biofilm Formation among Drug Resistant Uropathogenic Escherichia coli.
    Javed S; Mirani ZA; Pirzada ZA
    Libyan J Med; 2021 Dec; 16(1):1845444. PubMed ID: 33170767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut-bladder axis enters the stage: Implication for recurrent urinary tract infections.
    Salazar AM; Neugent ML; De Nisco NJ; Mysorekar IU
    Cell Host Microbe; 2022 Aug; 30(8):1066-1069. PubMed ID: 35952642
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Features of uropathogenic Escherichia coli able to invade a prostate cell line.
    Longhi C; Comanducci A; Riccioli A; Ziparo E; Marazzato M; Aleandri M; Conte AL; Lepanto MS; Goldoni P; Conte MP
    New Microbiol; 2016 Apr; 39(2):146-9. PubMed ID: 27196555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral supplementation of trans-cinnamaldehyde reduces uropathogenic Escherichia coli colonization in a mouse model.
    Narayanan A; Muyyarikkandy MS; Mooyottu S; Venkitanarayanan K; Amalaradjou MA
    Lett Appl Microbiol; 2017 Mar; 64(3):192-197. PubMed ID: 28063174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uropathogenic
    Stærk K; Andersen MØ; Andersen TE
    J Med Microbiol; 2022 Apr; 71(4):. PubMed ID: 35475768
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surfactant protein D inhibits adherence of uropathogenic Escherichia coli to the bladder epithelial cells and the bacterium-induced cytotoxicity: a possible function in urinary tract.
    Kurimura Y; Nishitani C; Ariki S; Saito A; Hasegawa Y; Takahashi M; Hashimoto J; Takahashi S; Tsukamoto T; Kuroki Y
    J Biol Chem; 2012 Nov; 287(47):39578-88. PubMed ID: 23012359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phylogenetic group distributions, virulence factors and antimicrobial resistance properties of uropathogenic Escherichia coli strains isolated from patients with urinary tract infections in South Korea.
    Lee JH; Subhadra B; Son YJ; Kim DH; Park HS; Kim JM; Koo SH; Oh MH; Kim HJ; Choi CH
    Lett Appl Microbiol; 2016 Jan; 62(1):84-90. PubMed ID: 26518617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of prevalence, immunogenicity and efficacy of FyuA iron receptor in uropathogenic Escherichia coli isolates as a vaccine target against urinary tract infection.
    Habibi M; Asadi Karam MR; Bouzari S
    Microb Pathog; 2017 Sep; 110():477-483. PubMed ID: 28754265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycobiology of uropathogenic E. coli infection: the sweet and bitter role of sugars in urinary tract immunity.
    Lupo F; Ingersoll MA; Pineda MA
    Immunology; 2021 Sep; 164(1):3-14. PubMed ID: 33763853
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.